Clinical

Dataset Information

0

S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer


ABSTRACT: This phase II trial is studying how well lapatinib works in treating patients with locally advanced or metastatic stomach cancer. Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

DISEASE(S): Diffuse Adenocarcinoma Of The Stomach,Adenocarcinoma,Recurrent Gastric Cancer,Intestinal Adenocarcinoma Of The Stomach,Stage Iv Gastric Cancer,Stomach Neoplasms,Stage Iii Gastric Cancer,Mixed Adenocarcinoma Of The Stomach

PROVIDER: 2012257 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| phs001570 | dbGaP
| 2040104 | ecrin-mdr-crc
| 2368674 | ecrin-mdr-crc
| 2079139 | ecrin-mdr-crc
2012-06-30 | GSE38376 | GEO
| 2044656 | ecrin-mdr-crc
2024-09-26 | PXD054180 | Pride
2013-10-31 | GSE51889 | GEO
| PRJNA708187 | ENA
| 2348654 | ecrin-mdr-crc